2016
DOI: 10.18383/j.tom.2016.00208
|View full text |Cite
|
Sign up to set email alerts
|

Test–Retest Data for Radiomics Feature Stability Analysis: Generalizable or Study-Specific?

Abstract: Radiomics is an objective method for extracting quantitative information from medical images. However, in radiomics, standardization, overfitting, and generalization are major challenges to be overcome. Test–retest experiments can be used to select robust radiomic features that have minimal variation. Currently, it is unknown whether they should be identified for each disease (disease specific) or are only imaging device-specific (computed tomography [CT]-specific). Here, we performed a test–retest analysis on… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
120
0
3

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 148 publications
(135 citation statements)
references
References 22 publications
(17 reference statements)
6
120
0
3
Order By: Relevance
“…Although these studies are relevant to create awareness of the influencing factors, it should be noted that the information is often not directly helpful to future studies. The reproducibility of radiomic features is not necessarily generalizable to different disease sites, modalities, or scanners, e.g., robust features in one disease site are not necessarily robust in another disease site [32]. Moreover, in case robust radiomic features are assessed using cut-off values of correlation coefficients, one should be aware that these cut-offs are often arbitrarily chosen and the number of "robust" features depend on the number of subjects involved.…”
Section: Current Limitations In Radiomicsmentioning
confidence: 99%
“…Although these studies are relevant to create awareness of the influencing factors, it should be noted that the information is often not directly helpful to future studies. The reproducibility of radiomic features is not necessarily generalizable to different disease sites, modalities, or scanners, e.g., robust features in one disease site are not necessarily robust in another disease site [32]. Moreover, in case robust radiomic features are assessed using cut-off values of correlation coefficients, one should be aware that these cut-offs are often arbitrarily chosen and the number of "robust" features depend on the number of subjects involved.…”
Section: Current Limitations In Radiomicsmentioning
confidence: 99%
“…Image acquisition A Different scanners and acquisition protocols affect feature reproducibility [79][80][81][82][83][84][85][86][87][88][89][90][91] Image phantoms on different scanners to provide baseline [79], establish credibility of scanners and protocols [84], catalogue reproducible features [86,90], model a correction algorithm [89] [98,[110][111][112] Normalization of features to volume [98], bit depth resampling [110], feature redesign [110], more robust statistics to check added value of radiomics signatures [111]. Test re-test H Radiomic features may not be repeatable over multiple measurements [113][114][115], repeatable features are not generalizable to other disease sites [116].…”
Section: Problem Area Potential Problems Potential Solutionsmentioning
confidence: 99%
“…Test-retest data acquisition [113,116], use of multiple 4D phases [113,115], use of simulated retest by image perturbation [114].…”
Section: Problem Area Potential Problems Potential Solutionsmentioning
confidence: 99%
See 1 more Smart Citation
“…Overfitting occurs when a model begins to memorise training data rather than learning to generalise from a trend. The main cause of overfitting in radiomics is the application of too many features, which become redundant and irrelevant (so-called noise); the excessive number of features can be reduced by test–retest studies that enable the selection of only those robust features that provide repeatable and reproducible measurements [ 9 , 26 , 27 ].…”
Section: Radiomics Applications In Oncologymentioning
confidence: 99%